المؤلفون: Rosenstock, Julio, Mathieu, Chantal, Chen, Hungta, Garcia-Sanchez, Ricardo, Saraiva, Gabriela Luporini

المصدر: Archives of Endocrinology and Metabolism. August 2018 62(4)

مصطلحات موضوعية: Dapagliflozin, type 2 diabetes, SGLT2 inhibitor

وصف الملف: text/html

الوصول الحر: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972018000400424Test

المؤلفون: Pettus, Jeremy, Boeder, Schafer C, Christiansen, Mark P, Denham, Douglas S, Bailey, Timothy S, Akturk, Halis K, Klaff, Leslie J, Rosenstock, Julio, Cheng, Mickie HM, Bode, Bruce W, Bautista, Edgar D, Xu, Ren, Yan, Hai, Thai, Dung, Garg, Satish K, Klein, Samuel

المصدر: Nature Medicine. 28(10)

مصطلحات موضوعية: Biomedical and Clinical Sciences, Clinical Sciences, Diabetes, Autoimmune Disease, Prevention, Clinical Trials and Supportive Activities, Clinical Research, 5.1 Pharmaceuticals, 6.1 Pharmaceuticals, Evaluation of treatments and therapeutic interventions, Development of treatments and therapeutic interventions, Metabolic and endocrine, Adult, Antibodies, Monoclonal, Humanized, Blood Glucose, Blood Glucose Self-Monitoring, Diabetes Mellitus, Type 1, Double-Blind Method, Glucagon, Glycated Hemoglobin, Humans, Insulin, Lipoproteins, LDL, Receptors, Glucagon, Transaminases, Treatment Outcome, Medical and Health Sciences, Immunology, Biomedical and clinical sciences, Health sciences

وصف الملف: application/pdf

الوصول الحر: https://escholarship.org/uc/item/4zh8n26kTest

المؤلفون: Januzzi, James, L, del Prato, Stefano, Rosenstock, Julio, Butler, Javed, Ezekowitz, Justin, Ibrahim, Nasrien, E, Lam, Carolyn S.P., Marwick, Thomas, Wilson Tang, W, H, Liu, Yuxi, Mohebi, Reza, Urbinati, Alessia, Zannad, Faiez, Perfetti, Riccardo

المساهمون: Massachusetts General Hospital Boston, Harvard Medical School Boston (HMS), Baim Institute for Clinical Research Boston MA, Scuola Universitaria Superiore Sant'Anna Pisa (SSSUP), University of Texas Southwestern Medical Center, Baylor Scott & White Research Institute (BSWRI), University of Mississippi Medical Center (UMMC), University of Alberta, Brigham and Women's Hospital Boston, National Heart Centre Singapore (NHCS), Duke-NUS Medical School Singapore, Baker Heart and Diabetes Institute (AUSTRALIA), Menzies Institute for Medical Research, Cleveland Clinic, Applied Therapeutics, Centre d'investigation clinique plurithématique Pierre Drouin Nancy (CIC-P), Centre d'investigation clinique Nancy (CIC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Cardiovascular and Renal Clinical Trialists Vandoeuvre-les-Nancy (INI-CRCT), Institut Lorrain du Coeur et des Vaisseaux Louis Mathieu Nancy, Défaillance Cardiovasculaire Aiguë et Chronique (DCAC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), French-Clinical Research Infrastructure Network - F-CRIN Paris (Cardiovascular & Renal Clinical Trialists - CRCT ), The ARISE-HF Trial is supported by Applied Therapeutics, Inc.

المصدر: ISSN: 1475-2840 ; Cardiovascular Diabetology ; https://hal.univ-lorraine.fr/hal-04435381Test ; Cardiovascular Diabetology, 2024, 23 (1), pp.49. ⟨10.1186/s12933-024-02135-z⟩.

مصطلحات موضوعية: Diabetes Cardiomyopathy Heart failure, Diabetes, Cardiomyopathy, Heart failure, [SDV]Life Sciences [q-bio]

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/38302936; hal-04435381; https://hal.univ-lorraine.fr/hal-04435381Test; https://hal.univ-lorraine.fr/hal-04435381/documentTest; https://hal.univ-lorraine.fr/hal-04435381/file/s12933-024-02135-z.pdfTest; PUBMED: 38302936; PUBMEDCENTRAL: PMC10835978

الإتاحة: https://doi.org/10.1186/s12933-024-02135-zTest
https://hal.univ-lorraine.fr/hal-04435381Test
https://hal.univ-lorraine.fr/hal-04435381/documentTest
https://hal.univ-lorraine.fr/hal-04435381/file/s12933-024-02135-z.pdfTest

المؤلفون: Rosenstock, Julio, Juneja, Rattan, Beals, John M, Moyers, Julie S, Ilag, Liza, McCrimmon, Rory J

المصدر: Rosenstock , J , Juneja , R , Beals , J M , Moyers , J S , Ilag , L & McCrimmon , R J 2024 , ' The Basis for Weekly Insulin Therapy : Evolving Evidence With Insulin Icodec and Insulin Efsitora Alfa ' , Endocrine Reviews . https://doi.org/10.1210/endrev/bnad037Test

العلاقة: https://discovery.dundee.ac.uk/en/publications/6ce0b875-e77d-48b6-a9a4-d8366583b4f0Test

الإتاحة: https://doi.org/10.1210/endrev/bnad037Test
https://discovery.dundee.ac.uk/en/publications/6ce0b875-e77d-48b6-a9a4-d8366583b4f0Test

المؤلفون: Rosenstock, Julio, Cariou, Bertrand, Eliasson, Johanna, Frappin, Guillaume, Kaltoft, Margit S., Montanya, Eduard, Knop, Filip K.

المصدر: Rosenstock , J , Cariou , B , Eliasson , J , Frappin , G , Kaltoft , M S , Montanya , E & Knop , F K 2024 , ' Greater time spent with HbA1c less than 7.0% with oral semaglutide versus oral comparators : An exploratory analysis of the PIONEER studies ' , Diabetes, Obesity and Metabolism , vol. 26 , no. 2 , pp. 532-539 . https://doi.org/10.1111/dom.15339Test

مصطلحات موضوعية: antidiabetic drug, GLP-1 analogue, glycaemic control, incretin therapy, semaglutide, type 2 diabetes

وصف الملف: application/pdf

الإتاحة: https://doi.org/10.1111/dom.15339Test
https://curis.ku.dk/portal/da/publications/greater-time-spent-with-hba1c-less-than-70-with-oral-semaglutide-versus-oral-comparatorsTest(56dd2288-fd1d-42ac-b2c6-cb1b0abf1bbc).html
https://curis.ku.dk/ws/files/379652890/Diabetes_Obesity_Metabolism_2023_Rosenstock_Greater_time_spent_with_HbA1c_less_than_7_0_with_oral_semaglutide_versus.pdfTest

المؤلفون: Bergenstal, Richard M., Philis‐Tsimikas, Athena, Wysham, Carol, Carr, Molly C., Bue‐Valleskey, Juliana M., Botros, Fady T., Blevins, Thomas, Rosenstock, Julio

المساهمون: Eli Lilly and Company

المصدر: Diabetes, Obesity and Metabolism ; ISSN 1462-8902 1463-1326

الإتاحة: https://doi.org/10.1111/dom.15604Test

المؤلفون: Giorgino, Francesco, Guja, Cristian, Aydın, Hasan, Lauand, Felipe, Melas-Melt, Lydie, Rosenstock, Julio

المساهمون: Sanofi

المصدر: Diabetes Research and Clinical Practice ; volume 209, page 111604 ; ISSN 0168-8227

مصطلحات موضوعية: Endocrinology, General Medicine, Endocrinology, Diabetes and Metabolism, Internal Medicine

الإتاحة: https://doi.org/10.1016/j.diabres.2024.111604Test
https://api.elsevier.com/content/article/PII:S0168822724000883?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S0168822724000883?httpAccept=text/plainTest

المؤلفون: Januzzi, James, L, Butler, Javed, del Prato, Stefano, Ezekowitz, Justin, A, Ibrahim, Nasrien, E, Lam, Carolyn S.P., Lewis, Gregory, D, Marwick, Thomas, H, Rosenstock, Julio, Tang, W.H. Wilson, Zannad, Faiez, Lawson, Francesca, Perfetti, Riccardo, Urbinati, Alessia

المساهمون: Massachusetts General Hospital Boston, Baim Institute for Clinical Research Boston MA, Harvard Medical School Boston (HMS), Baylor Scott and White Research Institute Dallas, TX, USA, University of Mississippi Medical Center (UMMC), University of Pisa - Università di Pisa, University of Alberta, Harvard T.H. Chan School of Public Health, National Heart Centre Singapore (NHCS), Duke-National University of Singapore Graduate Medical School, Baker Heart and Diabetes Institute (AUSTRALIA), Dallas Diabetes Research Center at Medical City, Cleveland Clinic, Défaillance Cardiovasculaire Aiguë et Chronique (DCAC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Centre d'investigation clinique plurithématique Pierre Drouin Nancy (CIC-P), Centre d'investigation clinique Nancy (CIC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Cardiovascular and Renal Clinical Trialists Vandoeuvre-les-Nancy (INI-CRCT), Institut Lorrain du Coeur et des Vaisseaux Louis Mathieu Nancy, French-Clinical Research Infrastructure Network - F-CRIN Paris (Cardiovascular & Renal Clinical Trialists - CRCT ), Applied Therapeutics, The ARISE-HF Trial is sponsored by Applied Therapeutics, Inc. Dr. Januzzi is fundedin part by the Hutter Family Professorship

المصدر: ISSN: 0002-8703.

مصطلحات موضوعية: [SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/36372245; hal-03884375; https://hal.univ-lorraine.fr/hal-03884375Test; https://hal.univ-lorraine.fr/hal-03884375/documentTest; https://hal.univ-lorraine.fr/hal-03884375/file/1-s2.0-S0002870322002873.pdfTest; PUBMED: 36372245

الإتاحة: https://doi.org/10.1016/j.ahj.2022.11.003Test
https://hal.univ-lorraine.fr/hal-03884375Test
https://hal.univ-lorraine.fr/hal-03884375/documentTest
https://hal.univ-lorraine.fr/hal-03884375/file/1-s2.0-S0002870322002873.pdfTest

المؤلفون: Heerspink, Hiddo J.L., Apperloo, Ellen, Davies, Melanie, Dicker, Dror, Kandler, Kristian, Rosenstock, Julio, Sørrig, Rasmus, Lawson, Jack, Zeuthen, Niels, Cherney, David

المصدر: Heerspink , H J L , Apperloo , E , Davies , M , Dicker , D , Kandler , K , Rosenstock , J , Sørrig , R , Lawson , J , Zeuthen , N & Cherney , D 2023 , ' Effects of Semaglutide on Albuminuria and Kidney Function in People With Overweight or Obesity With or Without Type 2 Diabetes : Exploratory Analysis From the STEP 1, 2, and 3 Trials ' , Diabetes Care , vol. 46 , no. 4 , pp. 801-810 . https://doi.org/10.2337/dc22-1889Test

وصف الملف: application/pdf

العلاقة: https://research.rug.nl/en/publications/12d325eb-b5df-4989-a60d-26714cc43778Test

الإتاحة: https://doi.org/10.2337/dc22-1889Test
https://hdl.handle.net/11370/12d325eb-b5df-4989-a60d-26714cc43778Test
https://research.rug.nl/en/publications/12d325eb-b5df-4989-a60d-26714cc43778Test
https://pure.rug.nl/ws/files/918986696/dc221889.pdfTest
http://www.scopus.com/inward/record.url?scp=85151043698&partnerID=8YFLogxKTest

المؤلفون: Home, Philip D., McCrimmon, Rory J., Rosenstock, Julio, Blüher, Matthias, Pegelow, Katrin, Melas-Melt, Lydie, Djaballah, Khier, Giorgino, Francesco

المصدر: Home , P D , McCrimmon , R J , Rosenstock , J , Blüher , M , Pegelow , K , Melas-Melt , L , Djaballah , K , Giorgino , F 2023 , ' Findings for iGlarLixi versus BIAsp 30 confirmed in groups of people with type 2 diabetes with different biomedical characteristics ' , Diabetes, Obesity & Metabolism , vol. 25 , no. 3 , pp. 656-663 . https://doi.org/10.1111/dom.14907Test

مصطلحات موضوعية: iGlarLixi, GLP-1 analogue, basal insulin, insulin therapy, type 2 diabetes, glycaemic control, randomized trial, hypoglycaemia, /dk/atira/pure/subjectarea/asjc/1300/1310, name=Endocrinology, /dk/atira/pure/subjectarea/asjc/2700/2724, name=Internal Medicine, /dk/atira/pure/subjectarea/asjc/2700/2712, Diabetes and Metabolism

وصف الملف: application/pdf

العلاقة: https://discovery.dundee.ac.uk/en/publications/3da7c19c-0ce2-4e60-975f-b08cb0594421Test

الإتاحة: https://doi.org/10.1111/dom.14907Test
https://discovery.dundee.ac.uk/en/publications/3da7c19c-0ce2-4e60-975f-b08cb0594421Test
https://discovery.dundee.ac.uk/ws/files/95159832/Diabetes_Obesity_Metabolism_2022_Home_Findings_for_iGlarLixi_versus_BIAsp_30_confirmed_in_groups_of_people_with_type.pdfTest
http://www.scopus.com/inward/record.url?scp=85143231431&partnerID=8YFLogxKTest